A Study on Pharmaceutical Drug Recall

Author:

l. Bhalodiya Bansi1,Kumar J. Vyas Amit1,I. Patel Ajay1,V. Dudhrejiya Ashvin1,B. Patel Ashok2

Affiliation:

1. Department of Quality Assurance, B.K. Mody Government Pharmacy College, Rajkot, India.

2. Government Pharmacy College, Gandhinagar, India.

Abstract

The present study describes the pharmaceutical drug recall in different five countries to evaluate the drug recall that occurred in the last three successive years. The different countries have different regulations for drug recall. Drug product recall is an action taken to withdraw or remove a batch or an entire production run of drug product from distribution or use to return them to manufacturer.it is usually done due to deficiency in quality, safety and efficacy. In the USA, guidelines for drugs product recall are described under 21 CFR Parts 7, 107 and 1270. In Australia, guidelines for drugs product recall are described under section 65F of trade practices act 1974. In Canada, it includes under section 25 of Natural Health Products Regulations (NHPR). In India it includes under para 27 and 28 of schedule M. In South Africa SAHPRA (South African Health Products Regulatory Authority) guidelines are responsible for regulations of drug product recall. Majority of drug recalls occur in the United states due to various reasons. In 2020-2022 total 257 drugs were recalled in Last three years. In Canada and Australia 220 and 25 drugs are recalled respectively. India and South Africa have recalled 2 and 21 drugs respectively. By the observation we can conclude that India and South Africa have a smaller number of recalls. In the USFDA number of drug recalls are decreasing due to following up the laws and regulatory.

Publisher

A and V Publications

Reference26 articles.

1. Wikipedia the free encyclopedia “Product recall”, October 2022, https://en.wikipedia.org/wiki/Product_recall

2. Ashok B. Patel, Bhumi K. Jinja, Amit Kumar J. Vyas, Nilesh K. Patel, Ajay I. Patel, Devang B. Sheth, Sunny R. Shah. A Retrospective Study of Warning letters Issued by US FDA Over 2019-2021. Asian Journal of Pharmaceutical Research 2022; 12(4):295-1.

3. Luxminarayan L, Neha S, Amit V, et al. Asian journal of pharmaceutical research and development. Asian J Pharm Res Dev 2017; 5: 1–8.

4. Wikipedia, October 2022, en.wikipedia.org/wiki/Food_and_Drug_Administration

5. "US Food and Drugs Administration (USFDA). As amended through P.L. 114-255, Enacted December 13, 2016. Federal Food, Drug, and Cosmetic Act (FD&C Act). United States Code, Title 21. 2016; October 2022, https://www.fda.gov/regulatoryinformation/lawsenforcedbyfda/federalfooddrugan dcosmeticactfdcact/defaul t.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3